Ethyl 2-[[(2S)-2-(1,3-dioxoisoindol-2-yl)propanoyl]amino]-3-fluoro-3-phenylpropanoate
C22H21FN2O5 — CID 134853991
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl 2-[[(2S)-2-(1,3-dioxoisoindol-2-yl)propanoyl]amino]-3-fluoro-3-phenylpropanoate
Ethyl 2-[[(2S)-2-(1,3-dioxoisoindol-2-yl)propanoyl]amino]-3-fluoro-3-phenylpropanoate (PubChem CID 134853991) has the molecular formula C22H21FN2O5 and a molecular weight of 412.42 g/mol. Its IUPAC name is ethyl 2-[[(2S)-2-(1,3-dioxoisoindol-2-yl)propanoyl]amino]-3-fluoro-3-phenylpropanoate.
Molecular Properties
| Compound Name | Ethyl 2-[[(2S)-2-(1,3-dioxoisoindol-2-yl)propanoyl]amino]-3-fluoro-3-phenylpropanoate |
|---|---|
| PubChem CID | 134853991 |
| Molecular Formula | C22H21FN2O5 |
| Molecular Weight | 412.42 g/mol |
| Exact Mass | 412.14 |
| IUPAC Name | ethyl 2-[[(2S)-2-(1,3-dioxoisoindol-2-yl)propanoyl]amino]-3-fluoro-3-phenylpropanoate |
| SMILES | CCOC(=O)C(NC(=O)[C@H](C)N1C(=O)c2ccccc2C1=O)C(F)c1ccccc1 |
| InChI | InChI=1S/C22H21FN2O5/c1-3-30-22(29)18(17(23)14-9-5-4-6-10-14)24-19(26)13(2)25-20(27)15-11-7-8-12-16(15)21(25)28/h4-13,17-18H,3H2,1-2H3,(H,24,26)/t13-,17?,18?/m0/s1 |
| InChIKey | UOZXYGVTKUKLEF-TZYSRNFLSA-N |
| XLogP | 2.43 |
| TPSA | 92.78 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 412.42 |
| LogP ≤ 5 | 2.43 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134853991 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.